上海合晶：2025年前三季度净利润约1.05亿元

Group 1 - Shanghai Hejing reported a revenue of approximately 1.006 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 19.05% [1] - The net profit attributable to shareholders for the same period was approximately 105 million yuan, showing a year-on-year increase of 32.86% [1] Group 2 - As of the report date, Shanghai Hejing's market capitalization stands at 16.1 billion yuan [2] - The Chinese innovative drug sector has seen overseas licensing sales reach 80 billion US dollars this year [2]